Similar to the standard radiotherapy (400 MU/min), melanoma cells exhibit resistance to 400 MU/min in Rad ×1 to Rad ×4 (total dose 2 Gy), even in the presence of Paclitaxel. The gene discussed is RRAD; the disease is melanoma.